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                                    “Where the sun shines, there too is shadow.  
Be illumined by the light of knowledge no less than by its shadow.” 
 
Halcolm - qualitative inquiry muse (1980-) by Patton, 2002

  
ABSTRACT 
Life with peripheral arterial disease and the resulting impaired walking ability leads to 
major limitations in daily life and a decreased quality of life. The overall aim of this 
thesis was to generate understanding about the life situation among people living with 
peripheral arterial disease and their family members.  
 
The outcomes after percutaneous transluminal angioplasty interventions both proximal 
and distal to the inguinal ligament were assessed by collecting data by means of chart 
review using a study specific protocol. The results show a connection between 
proximal intervention and age as well as proximal intervention and smoking. Patients in 
the proximal group were younger and more frequent smokers or former smokers and 
hematomas/bruises as a complication were more common among non-diabetic patients 
(Paper I). 
 
Health related quality of life in patients with peripheral arterial disease undergoing 
percutaneous transluminal angioplasty intervention was investigated using a general 
questionnaire (EQ5D) as well as a disease-specific questionnaire (CLAU-S) translated 
into Swedish for this study. The health related quality of life was improved both one 
month and one year after the percutaneous transluminal angioplasty compared to before 
the intervention (Paper II). 
 
The experiences of living with intermittent claudication were studied through 
qualitative interviews with individuals suffering from peripheral arterial disease. The 
interviews were analyzed by thematic content analysis and six themes together founded 
a main theme concerning adjusting to a restricted life when living with intermittent 
claudication (Paper III).  
 
Spouses and cohabitants were interviewed about their experiences of living together 
with a person suffering from intermittent claudication. The overall theme was about 
living a demanding life when living together with someone with intermittent 
claudication. The findings of this study give insight into the complexities and the 
difficulties of ageing and living together with someone suffering from intermittent 
claudication (Paper IV). 
 
In conclusion, living with intermittent claudication has a major impact on daily life and 
demands adjustment to a restricted life. Percutaneous transluminal angioplasty 
improves health related quality of life among individuals suffering from peripheral 
arterial disease and the effect is sustainable over time up to one year after the 
intervention. People who had undergone percutaneous transluminal angioplasty were 
younger in the proximal group and hematomas/bruises were more common among non-
diabetic patients. Ageing and intermittent claudication have great impact on both the 
spouse’s and the ill person’s life situation.  
 
Keywords: Peripheral Vascular Disease; Experiences; Angioplasty, balloon; Health 
related quality of life; Life situation; Family members 
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INTRODUCTION 
Living with peripheral arterial disease is associated with pain, impaired mobility and 
loss of control. Both physical and social functions are often negatively affected as well 
as health related quality of life. Peripheral arterial disease is a chronic disease usually 
due to arteriosclerosis, leading to narrowing blood vessels with ischemic injury as a 
result, causing symptoms of intermittent claudication or critical limb ischemia 1. The 
life situation is affected for both the ill person and their family members.  
 
With the demographic profile shifting to an aging population it is quite possible that the 
occurrence of peripheral arterial disease will increase in the future 2 since this disease 
has higher prevalence in old age 3. 
 
Percutaneous transluminal angioplasty (PTA) is a well-established method of treatment 
for peripheral arterial disease. Previous studies have shown that health related quality of 
life (HRQoL) was improved by treatment using percutaneous transluminal 
angioplasty4-9. There is however a lack of research concerning HRQoL in patients with 
peripheral arterial disease undergoing percutaneous transluminal angioplasty assessed 
with disease-specific questionnaires 10. 
 
It is important to gain knowledge about how individuals suffering from illness are 
affected in daily life and how this corresponds to the expectations the person has on 
life. To understand how quality of life changes when subjected to different treatments 
and interventions is also essential to understand the ill person’s needs. 
 
In my clinical work as a registered nurse I have met a lot of patients suffering from 
peripheral arterial disease and some of them have undergone percutaneous transluminal 
angioplasty. During the course of the studies in this thesis I have had the opportunity to 
learn about the outcomes of the PTA-interventions and how the intervention affected 
the patient’s quality of life. When a person is suffering from chronic illness, the 
consequences of the diagnosis and the illness itself affect the person as well as their 
family members. I have had the privilege of listening to both people suffering from 
peripheral arterial disease and their family members, telling me their stories about the 
experiences of life with peripheral arterial disease. Since the family members are an 
essential part of the ill person’s life it is of great importance for health care 
professionals to gain knowledge concerning both the patients’ and the family members’ 
situation to be able to understand and treat the patient appropriately. 
 
This thesis is intended to make a contribution to enhance the knowledge and 
understanding of the life situation among people suffering from peripheral arterial 
disease as well as the experiences of their family members.  
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BACKGROUND 
 
LIVING WITH CHRONIC ILLNESS 
Living with chronic illness often leads to a more restricted life, loss of control and 
social isolation 11. Both physical and social functions are often negatively affected 12-13 
and those suffering from chronic illness can also miss their previous life 14-15. Being 
diagnosed with chronic illness changes the ill person’s view of the future 16 and life 
with chronic illness can give a feeling of being a burden to others 12-13.  
 
In order to understand what life with a chronic illness is like it is essential to get the ill 
person’s perspective of daily life with illness. This inside perspective is described by 
Conrad 17 as a subjective perspective (the ill person’s perspective), as opposed to the 
outside perspective where you see the illness and the patient as a diagnosis or an object. 
By listening to people’s stories, so called ”illness narratives” 18-19, we can learn more 
about what life is like with different illnesses and thereby get an increased 
understanding for their situation. This increased understanding can in turn improve the 
treatment of and the respect for the individual.  
 
There is however a risk that an ill person is not taken seriously if the illness cannot be 
proven medically by, for instance a diagnosis since one can suffer from an illness 
without having a medically proven disease 19-20. Unfortunately many feel they are not 
taken seriously 21 or that health care professionals think they know the ill person’s 
needs without even asking and treat them like an object without a will of their own 22. 
To be treated well and to get confirmation from others is important when living with 
chronic illness just as the opposite can give a feeling of being questioned or of being of 
less value than before the illness 23.  
 
Life with chronic illness is all about being ”a whole person” as opposed to ”a patient” 24 
if the ill person does not allow him/herself to be defined by the disease. This can be 
described as the subjective (the ill person) experience and the objective (e g healthcare) 
opinion of living with illness 25. Healthcare today is often disease oriented and not 
patient oriented, which may cause problems when patients with the same diagnosis are 
all treated the same way. This in turn may cause problems for instance when a patient is 
being discharged from the hospital and after-care is not fully planned and thought 
through properly 24. 
 
An inside perspective of illness should according to Conrad 17 include the ill person’s 
feelings of how the illness has changed them in their own view, but also when seen 
through other’s eyes. It is not unusual that a person with an illness changes in 
appearance, has a different way of moving and no longer has complete control of the 
body. This can lead to stigmatization and thereby lead to problems in the relationship 
with other people 26. Regrettably there are many examples of people with illness who 
feel that those close to them distance themselves or suddenly treat them differently 
because of the illness 22, 27-28. An example could be friends crossing to the other side of 
the street when you are about to meet on the sidewalk.  
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Chronic illness is a threat to the ill person’s identity 17 and self-image. People with 
chronic illness can suffer greatly from this loss of self-image because when it is lost it 
is not replaced by a new, comparable self-image. Instead the ill persons decrease their 
life activities and sometimes even isolate themselves from the outside world 11. To 
understand what has happened and to get an explanation of the changes caused by the 
illness can make it easier to incorporate the illness 21, 27 in life and to gain new self-
image 11. 
 
Chronic illness affects life in different ways depending on if the illness is life 
threatening or not as well as on how much the symptoms affect the daily life 17, 29. 
When someone is suffering from pain or limited ability to move around, the illness is 
more apparent compared to someone suffering from high blood pressure for instance, 
where the blood pressure can be kept stable with adequate treatment. When someone is 
suffering from pain they have to learn how to handle the pain and not identify with it. 
When a diagnosis is made the illness can be seen in another, more objective way 19. 
 
In order to understand what it is like to live with illness it is important to know how the 
ill person first noticed that something was wrong and what this meant to them, what 
explanations they had for what was happening and how they adjusted to this change in 
life 17. The effects the diagnosis or the illness will have on daily life, the change from 
life in a family where everyone is healthy to suddenly living with someone suffering 
from chronic illness, can be a learning process for the entire family 25, 28. 
 
Many people suffering from chronic illness are not entirely independent; they may need 
daily assistance from others. It’s important for these people to receive help and to 
surround themselves with people they trust 27. Apart from the direct effects of the 
illness the ill person and their family members often have to struggle to manage all of 
the practical things in life. For instance, keeping track of and fitting in visits to doctors 
into the daily routine, arranging transportation, getting home-help service to work 
satisfactorily and so on, things that take a lot of their time. Often the ill person has to 
visit several different specialists that many times only see their specialized part and not 
the big picture, the entire scope of the person’s illnesses 24. For family members this 
could mean putting oneself in second place to be able to support the ill person or to 
support other relatives or friends when worried about how they are affected by the 
situation 30.  
 
The relationship between family members and the chronically ill person is affected in 
many ways. The family members and the consequences the disease has on their lives 
also require attention 14, 31. A deeper understanding of life with chronic illness and of 
how both the ill person and their family members are affected by the illness is needed 
in order for healthcare to develop and to treat those with chronic illness in a better way 
24. One way to gain deeper understanding is to pay attention to peoples’ stories of their 
life with chronic illness 17. 
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PERIPHERAL ARTERIAL DISEASE 
 
Epidemiology  
Peripheral arterial disease (PAD) is a chronic disease usually due to arteriosclerosis 
where the plaques lead to a narrowing lumen in the blood vessels (stenosis or 
occlusions). This causes obstruction of the of blood flow to peripheral tissues leading to 
ischemic injury 1. Peripheral arterial disease also indicates a more general 
arteriosclerosis and it is not unusual that people with PAD have coronary insufficiency 
or cerebrovascular disease. Persons afflicted by PAD are more likely to die from 
cardiovascular disease, e.g. myocardial infarction or stroke, compared to healthy people 
of the same age 3, 32.   
 
It is difficult to compare or transfer findings of different studies about incidence and 
prevalence of PAD to other populations since different symptoms, age groups or 
geographic areas can be assessed. Sometimes all cases may not have been recorded and 
consequently the prevalence may be even higher. According to existing studies the 
prevalence of intermittent claudication in a Swedish population aged between 60-90 
years was 6.8% in a recent study 33. In an earlier study the prevalence of PAD in a 
Swedish population was 4.1 % in the age range 50-89 years, which translates into 
approximately 2 % of the total population 34. The prevalence of PAD in an American 
community was 3 % in the age range 40-59 years, 8 % at 60-69 years and 19 % ≥ 70 
years 35. 
 
Risk factors for arteriosclerosis apart from age are tobacco smoking 36-37, diabetes, 
hypertension and hyperlipidemia 37. Peripheral arterial disease is equally prevalent 
among men and women 38-40. Women have a higher prevalence than men of 
asymptomatic PAD diagnosed with ankle-brachial index 41 and because of the similar 
risk of vascular morbidity and mortality in asymptomatic PAD, it is important to screen 
women for PAD 42. It is well known that PAD increases with age 43, as in the case with 
other chronic diseases and infirmities where occurrence peaks at 65 years and over 44.  
 
 
Symptoms 
PAD can be asymptomatic or become manifest as intermittent claudication or critical 
limb ischemia 1. The clinical classification of PAD is most often made by using 
Fontaine’s stages or Rutherford’s categories, see table 1 32. One characteristic feature of 
PAD is reduced walking ability or intermittent claudication caused by lower limb 
ischemia 45. The symptom intermittent claudication is cramping or aching in the leg 
while walking, which is relieved by a short rest 1 and is the earliest and most frequent 
symptom in people with lower extremity PAD. Pain while walking could be assumed to 
be a part of the natural ageing process and the lack of knowledge about PAD in the 
general public delays the seeking of medical help 12. Critical limb ischemia is a more 
severe manifestation of PAD and is defined by the symptoms of rest pain, necrosis and 
gangrene 1. 
 
 
   5 
Table 1. Fontaine’s stages and Rutherford’s categories of peripheral arterial disease 32. 
 
           Fontaine                   Rutherford 
Stage Clinical Grade Category Clinical 
I Asymptomatic 0 0 Asymptomatic 
IIa Mild claudication I 1 Mild claudication 
IIb Moderate to severe claudication 
I 
I 
2 
3 
Moderate claudication 
Severe claudication 
III Ischemic rest pain II III 
4 
5 
Ischemic rest pain 
Minor tissue loss 
IV Ulceration or gangrene III 6 Major tissue loss 
 
 
 
Diagnostic procedure  
Ankle Brachial Index (ABI) is used for diagnosis of PAD with a value lower than 0.9 
being accepted as diagnostic 46. ABI is used when assessing the lower extremity arterial 
perfusion and is a noninvasive diagnostic test 42. To measure ABI the highest systolic 
ankle pressure is divided by the systolic brachial pressure 32, 47. There are however 
differences in recommendation concerning how to measure ABI, using the highest or 
lowest or the mean systolic pressure of the two ankle arteries 2.  False high ABI can 
however be obtained if the arteries are heavily calcified and incompressible at the 
malleolar level. This is common among people suffering from diabetes and can lead to 
an underestimation of the severity of the disease 47. 
 
The WHO/Rose Questionnaire was developed in 1962 by G A Rose to diagnose 
intermittent claudication in field surveys 48. From the WHO/Rose Questionnaire the 
Edinburgh Claudication Questionnaire has been constructed to detect intermittent 
claudication, this corresponded well to the doctors’ diagnosis when evaluated 49. 
However detection of PAD among people with diabetes with the Edinburgh 
Claudication Questionnaire was low compared to a diagnosis based on ABI 50.  When 
assessing only with questionnaires there is a risk of overestimating the occurrence of 
PAD since other symptoms similar to those of PAD can come into account 43. 
Comorbidities such as spinal stenosis or neuropathy for example can sometimes be 
confused with PAD 45. The source of pain can be hard to distinguish and opposite to 
what is stated above this can result in an underestimated prevalence 51.  
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PERIPHERAL ARTERIAL DISEASE AS AN ILLNESS 
 
Living with peripheral arterial disease 
Living with PAD is associated with pain, impaired mobility and loss of control 52 and 
both physical and social functions are often negatively affected 12. The impaired 
walking ability leads to major limitations in daily life 53 and a decreased quality of life3, 
and people suffering from PAD are often concerned about the reduction in their 
walking ability 12-13, 54. Due to the effects of the decreased functional capacity people 
suffering from PAD sometimes require both support from other people as well as 
physical support like the use of a walking cane which is sometimes seen as 
embarrassing 55.  
 
Many are concerned about the reoccurring pain 53, worried about possible future 
amputation 12-13, 54 and those amputated can be afraid of falling, worried about getting 
phantom pains and the increased dependency on others 56. The reduced walking ability 
in turn leads to increased isolation because the person tends to be less active in leisure 
activities as well as other social activities 12-13, 54-55. Help from friends or family 
members is needed and this could give a feeling of being a burden to others 13 and loss 
of independence 55. Intermittent claudication is also associated with psychological 
factors such as impaired mood 57.  
 
It is well known that PAD increases with age 3 but pain while walking could be 
assumed to be a part of the natural ageing process, this and the lack of knowledge about 
PAD in the general public delays the seeking of medical help 12. Effective treatment 
methods in the form of medication and/or surgical interventions with open or 
endovascular methods such as bypass surgery or percutaneous transluminal angioplasty 
(PTA) can ease the symptoms and to a certain extent stop the progress of the disease, 
but is not curative 58. Increased knowledge concerning the experience of living with 
illness from the insider’s perspective is needed 17 to deepen the understanding of  
people living with PAD and to be able to improve their treatment.  
 
 
Health related quality of life  
Measuring health-related quality of life (HRQoL) has become increasingly important in 
evaluating people with PAD, both to understand the impact of the illness and to capture 
information regarding medical and nursing interventions. Functional status in 
intermittent claudication is assessed with objective measures like treadmill testing 
where the walking ability is determined by measuring time and/or distance of walking 
until onset of claudication and time and/or distance to termination of walking due to leg 
pain 59. This kind of measurement or functional status questionnaires like the Walking 
Impairment Questionnaire 60 or a health status questionnaire like the Peripheral Artery 
Questionnaire 61 do not however address to the individual’s perception of their situation 
or their HRQoL 62. Health related quality of life can be defined as a reflection of a 
person’s mental, physical and social beliefs and perceptions in relation to health and 
rests upon a concept of health as well as a concept of quality of life 63.  
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Health related quality of life is negatively affected by PAD, according to previous 
studies, due to fatigue, reduced mobility and pain 64-68. The person’s daily living is 
affected due to symptoms such as pain and decreased ability to walk. The feelings of 
loss of independence and isolation are often related to reduced physical mobility 12-13, 52-
53. The pain often interferes with sleep and some people even have to sleep sitting with 
the legs down on the floor due to the severe pain 53. The use of strong analgesics to 
reduce the pain can result in constipation and nausea that also affect the quality of life69.  
 
Health related quality of life can be assessed with generic as well as disease-specific 
instruments 63. 
 
Assessing health related quality of life with generic instruments  
Several studies have measured HRQoL over time in people with PAD with different 
kinds of generic instruments, applicable across populations irrespective of health 
conditions such as: EQ5D, Nottingham health profile and the SF-36 questionnaire 4-9. 
These studies have shown that the HRQoL increased in patients undergoing PTA by 
improving physical and psychological health and alleviating pain.  Remes et al 68 
compared HRQoL among patients who had undergone PTA or other vascular 
interventions to an age and gender matched control-group using the 15D HRQoL scale. 
People with PAD had an estimated lower HRQoL in all 15 dimensions of the 
questionnaire compared to the control-group who did not (as far as they knew) suffer 
from PAD 68. The relationship between mortality and HRQoL in people with PAD has 
been assessed using the EQ5D indicating a relationship between poor HRQoL and 
mortality 70.  
 
Assessing health related quality of life with disease-specific instruments 
To be able to properly understand how a certain disease and its’ symptoms affect the 
health related quality of life a disease-specific instrument should be used.  Disease-
specific questionnaires have been developed to assess health related quality of life in 
people suffering from symptomatic peripheral arterial disease. One of them is the 
Claudication-scale or CLAU-S, first developed in Germany 71-72 to examine the effect 
of a vasodilator (naftidrofuryl) on intermittent claudication. The CLAU-S includes five 
dimensions: every day life, pain, social life, illness-specific fears and psychological 
wellbeing. Other PAD disease-specific instruments are the Peripheral Artery Occlusive 
Disease 86 questionnaire or PAVK-86 73, the Vascular Quality of Life questionnaire or 
VascuQoL 74 and the Intermittent Claudication Questionnaire or ICQ 75. Mays et al 62 
suggest it is important to assess HRQoL and functional status in different clinical areas 
as well as in research as it may be of help in treatment decisions.  
 
 
Influence on family members 
The family members have to face the same symptoms and anxiety as the person 
diagnosed with PAD, often tying them to their homes, which results in a sense of 
isolation 55. Roles in the family often change radically and the family members are 
burdened with a heavier workload and reduced opportunities for recreational  
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activities 14, 55, 76. Family members need to take one day at a time to be able to cope 
with the ill person’s infirmity 77.  The family members also worry about the progression 
of the disease in general and the possibility of future amputation in particular since that 
could increase their already heavy burden. They also express that they feel powerless 
regarding their lack of ability to do anything to help the person suffering from PAD 55.  
 
 
SENSE OF COHERENCE 
The salutogenic model, focusing on health instead of disease was formulated by A. 
Antonovsky when he, after seeing the results of a study, wondered why such a large 
part of the women in the study (29%) stayed healthy despite their experiences of world 
war two concentration camps. His conclusion was that people have different general 
resistance recourses (GRR) such as ego, money, cultural stability, coping strategies and 
social support to handle the different stressors one is exposed to in life. Common to all 
GRR is that they make the stressors comprehensible. The ability of people’s 
understanding, managing and finding meaning in different situations led to the 
development of the concept sense of coherence 78. A standardized questionnaire was 
constructed to assess sense of coherence, which is a 29-item scale called The Sense of 
Coherence Scale (SOC) consisting of three dimensions: perceived comprehensibility, 
manageability and meaningfulness 79.  
 
A high sense of coherence predicts successful stress management and previous studies 
have shown a relation between high sense of coherence and better quality of life and 
wellbeing 7, 80-81. Klevesgård et al 7 illuminate the importance of SOC in a study with 
people suffering from varying degrees of lower limb ischemia where a higher SOC and 
ABI were associated with improvements of quality of life.  
 
 
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY 
Percutaneous transluminal angioplasty with or without stenting is an endovascular 
treatment method for peripheral arterial disease and is performed in the angiography 
laboratory under fluoroscopy under local anesthesia. A catheter with a rigid balloon is 
passed into the artery (with stenosis or occlusion) and inflation of the balloon dilates 
the blood vessel, which will improve flow. Percutaneous transluminal angioplasty is a 
well-established method of treatment for peripheral arterial disease 82. The first 
successful intervention was performed and presented in 1964 by C. Dotter and M. 
Judkins 83 and was at first used for the treatment of short stenosis of vessels proximal to 
the inguinal ligament. The development of technologies and instruments (e g 
development of stents, improved catheter and guide wire design) has improved and 
increased the use of the interventions 82 and PTA is now even used as treatment in 
long–segment occlusions distal to the inguinal ligament 32.  
 
If the guide wire cannot pass through the occlusion, for example in a completely 
occluded vessel or long segment occlusion, the technique of subintimal angioplasty can 
be used as described by A. Bolia and colleagues 84. This means the angioplasty balloon 
is manipulated into the subintimal plane at the outset of the occlusion and after it has 
passed the occlusion it is manipulated back into the lumen again below the occlusion. 
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The balloon is inflated and a subintimal passage has been established 84 with a technical 
success rate of 91.4 % in a recent study 85.  
 
Percutaneous transluminal angioplasty is less invasive than bypass surgery and is also 
associated with lower mortality and less risk of major morbidity. Compared to bypass 
surgery PTA also shortens the time needed to be able to return to normal activities 32. 
PTA can be used as a first course of treatment or as a complement to other types of 
surgery. Short-term outcomes at six months show a limb salvage rate of 97% 86 and in a 
one-year follow-up study none of the 78 patients required amputation 87. Long-term 
follow up at seven years shows a limb salvage rate of 93% 88. There are no differences 
in duration of patency between men and women regarding outcomes after PTA 89. A 
major significant risk factor for adverse outcome after PTA-intervention is smoking 
history 88.  
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RATIONALE 
Life with peripheral arterial disease and the resulting impaired walking ability leads to 
major limitations in daily life and a decreased quality of life.  
 
In order to understand what living with peripheral arterial disease is like it is essential 
to get the ill person’s perspective of daily life with illness. One way to gain deeper 
understanding is to pay attention to peoples’ stories of their life and their experiences of 
living with peripheral arterial disease. This insider’s perspective and knowledge 
concerning both the illness and the disease is needed to be able to understand the ill 
person’s needs and to improve their treatment. 
 
The relationship between family members is affected in many ways when a person is 
stricken by chronic illness. The consequences peripheral arterial disease have on the 
lives of those close to the ill person also require attention. A deeper understanding of 
life with chronic illness and of how both the ill person and their family members are 
affected by the illness is needed in order for healthcare providers to develop and to treat 
those with chronic illness in a better way.  
 
Peripheral arterial disease can be treated with percutaneous transluminal angioplasty, 
which is a well-established endovascular treatment method. To be able to evaluate the 
intervention it is important to describe the outcomes and also to find out how this 
treatment affects the health related quality of life. For a proper understanding of this a 
disease-specific instrument should be used.  There is however a lack of research 
concerning HRQoL in patients with peripheral arterial disease undergoing PTA 
assessed with disease-specific questionnaires. This gap needs to be addressed  in order 
to obtain increased knowledge of how specific domains of HRQoL are affected in order 
to be able to better develop the care of this particular patient group.  
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AIMS OF THE THESIS 
The overall aim of this thesis is to generate understanding about the life situation 
among people living with peripheral arterial disease and their family members. The 
specific aims were: 
 
I. to describe the characteristics of all patients who have undergone PTA at a 
University Hospital in Sweden between 1998 and 2002 and to describe the 
outcomes of interventions proximal and distal to the inguinal ligament. 
 
II. to investigate HRQoL over time in patients with PAD undergoing PTA. 
 
III. to describe individuals’ experiences of living with intermittent claudication 
due to peripheral arterial disease from an insider’s perspective. 
 
IV. to describe family members’ experiences of living with a person suffering 
from intermittent claudication caused by peripheral arterial disease. 
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METHODS 
 
Table 2. Overview of the methods in Paper I-IV. 
 
 Paper I  Paper II Paper III Paper IV 
Design  Retrospective 
descriptive  
Prospective 
longitudinal  
Qualitative 
descriptive  
Qualitative 
descriptive  
Participants 188 patients 
(77 men and 
111 women) 
41 patients  
(21 men and 20 
women) 
15 individuals 
suffering from 
intermittent 
claudication  
(8 men and 7 
women) 
10 spouses  
(3 men and 7 
women)  
Inclusion 
criteria 
All patients 
undergoing 
PTA between 
1998-2002  
Patient schedule 
for PTA  
People living 
with 
intermittent 
claudication 
Cohabitant 
with a person 
living with 
intermittent 
claudication 
Age, mean Mean age 
71±10.1 years, 
range 40-90 
years 
Mean age 68 
years, range 47-
87 years 
Mean age 73 
years, range 
64-81 years  
Age range 65-
79 years 
Data 
collection 
 
Chart review: 
A study-
specific 
protocol 
Questionnaire: 
CLAU-S, 
EQ5D, SOC 
Qualitative 
interviews 
Qualitative 
interviews 
Analysis Descriptive,  
The Pearson 
Chi-square test 
and t-test 
Descriptive 
Mann-Whitney 
test, pair wise t-
test and 
Kruskal-Wallis 
Qualitative 
thematic 
analysis 
Qualitative 
thematic 
analysis 
Abbreviations: CLAU-S = Claudication scale, EQ5D = EuroQol questionnaire, SOC = 
Sense of Coherence scale. 
 
 
DESIGN 
The collection of data through patient records, questionnaires and qualitative interviews 
provides a broad understanding of the life situation among people living with peripheral 
arterial disease, those going through PTA-interventions, as well as their family 
members.  
 
A retrospective descriptive design was chosen for Paper I where the data was collected 
by reviewing patient records to obtain knowledge about the outcomes after PTA- 
interventions.  
 
To be able to follow up and gain knowledge about people’s health related quality of life 
after PTA-interventions a prospective longitudinal design was used in Paper II. There 
was no control-group; the aim of the study was to scrutinize the patients’ health related 
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quality of life over time and not to compare this with other groups. The use of a generic 
questionnaire (EQ5D) facilitates the comparison with other studies (even involving 
other diseases) using the same questionnaire.  
 
Qualitative thematic analysis was applied in Paper III-IV. The data giving the insider’s 
perspective of the experiences of living with intermittent claudication (Paper III) and 
the experiences of living together with someone suffering from intermittent 
claudication (Paper IV) were collected through qualitative interviews.  
 
 
SAMPLE AND PROCEDURE 
 
Participants 
A total of 254 (Paper I n=188; Paper II n=56, 41 completed; Paper III n= 15; Paper IV 
n=10) people living with peripheral arterial disease and spouses living with people 
suffering from intermittent claudication were included in the different studies in this 
thesis. One person included in Paper II, also participated in Paper III.  
 
All patients treated with PTA due to PAD at a University Hospital in Sweden between 
January 1st 1998 and December 31st 2002 were included in Paper I. The samples for 
Paper II-IV were recruited from another University Hospital in Sweden between 
December 2005 and June 2007 (Paper II) and between November 2009 and June 2010 
(Paper III-IV).  The inclusion criteria in Paper II were patients with PAD who were 
scheduled for PTA (with or without stenting) and acceptance for participation. The 
inclusion criteria in Paper III were people diagnosed with intermittent claudication due 
to PAD and listed for visits/revisits to the vascular surgery department. In Paper IV the 
inclusion criterion was cohabitant (spouses) to a person diagnosed with peripheral 
arterial disease, suffering from intermittent claudication. Exclusion criterion in Paper 
II-IV was not speaking or understanding the Swedish language. 
 
The catchment area of the hospital in Paper I covered a mainly urban population of  
450 000 people. In Paper II-IV the hospital’s catchment area covered a population of 
800 000 people. The sample technique for Paper III-IV was purposive sampling to 
select a sample with a wide range of duration of their intermittent claudication 
symptoms, both men and women of different ages and to get information-rich cases 90.  
 
Drop-outs  
Out of the 56 participants included in Paper II, 47 patients participated at the one-month 
follow-up and 41 patients completed the one-year follow-up. Out of the fifteen 
participants who were lost to follow-up: eight did not wish to participate any longer, 
three had developed other serious diseases, one had died and three could not be located. 
 
 
Data collection and procedure 
In Paper I the data were extracted verbatim from the patients’ medical and nursing 
records from surgical, medical, orthopedic and geriatric clinics at the hospital and all 
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data was collected by the same person (L.E.). In order to identify the sample and for 
data collection (e.g. anatomic treatment location, revascularizations and re-operations), 
the nationwide registry of vascular and endovascular surgery in Sweden, Swedvasc, 
was used by permission from its Board. Only the first endovascular intervention (PTA) 
per patient during the period was included. Procedures after the included PTA-
intervention on the same leg were referred to as “re-PTA/re-operation” and any 
vascular/endovascular operations prior to the study period were termed “previous 
operations”.   
 
Medical and nursing records were reviewed to obtain demographic and medical 
characteristics in Paper II, e.g. age, gender, smoking habits, diseases relevant to 
peripheral arterial disease (e.g. stroke, hypertension, myocardial infarction and 
diabetes) and complications after the vascular treatment (e.g. hematoma at the puncture 
site) repeated revascularizations, reoperations of the same leg and amputation. Data for 
health related quality of life were collected by two different questionnaires, CLAU-S 
and EQ5D and the sense of coherence by the Sense of Coherence scale, SOC. All three 
questionnaires were distributed to the participant at the hospital the same day or the day 
after the intervention (baseline). Follow-up was carried out one month and one year 
after PTA-intervention, the questionnaires (CLAU-S and EQ5D) were then sent by 
mail to the participants. The Individual National Registration Records were checked to 
see whether the participants were still alive at either follow-up prior to mailing.  
 
Twenty-five interviews were carried out (15 in Paper III and 10 in Paper IV) during 
winter and spring 2009-2010. The purpose of the qualitative interviews was to gather as 
much information as possible with focus on the content of the interview and to 
interview enough people to capture the variations of different experiences of the same 
phenomena.  This is more dependent on the skills of the inquirer and the depths of the 
interviews rather than sample size 90. There are no strict rules as to the number of 
participants in a qualitative study. According to Kvale and Brinkmann 91 the size of the 
sample should be between 5-25 people. All interviews were conducted by the same 
person (L.E.), in the participant’s home (n=19), in a room at the author’s working place 
(n=4), in a room at the hospital (n=1) and by telephone (n=1) according to the 
participant’s preference. The interviews were all audio recorded and lasted 
approximately 40-100 minutes, transcribed verbatim and then carefully compared to the 
original recordings to assure no words or sentences were written incorrectly and 
thereby influencing the interpretation later on.  
 
  
Questionnaires 
 
Study specific protocol 
A study specific protocol was developed (Paper I) based on scientific literature issues 
and clinical experience of two vascular surgeons and a registered nurse (L.E.) 
experienced in the care of vascular patients. Scientific papers and textbooks concerning 
PAD and PTA were reviewed in order to gain deeper knowledge about diagnoses, 
symptoms, living with PAD, conservative-, medical- and surgical treatments placing 
emphasis on PTA-procedures and outcomes. The variables included in the protocol 
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were continuously questioned and confirmed by discussions within the research group 
during the development and then tested on randomly selected patient records. The 
protocol finally included: age, gender, legal and social status, home help service, 
anatomic treatment location (distal or proximal to the inguinal ligament), smoking 
history, co-morbidities (e.g. diabetes, myocardial infarction, stroke and hypertension), 
ulcers, pain before and after the revascularization, complications after the intervention 
such as hematoma at the puncture site, re-operations or revascularizations of the same 
vessel, amputations and survival rate. 
 
The questionnaires in Paper II were the Claudication scale, EuroQol 5D and the Sense 
of Coherence scale.  
 
Claudication scale (CLAU-S) 
CLAU-S is a peripheral arterial disease specific instrument, first developed in  
Germany 71-72. The questionnaire includes 47 items grouped in 5 dimensions:  
1. Every day life. How do you manage in every day life? 
2. Pain. How frequent and how severe is the pain in the affected leg? 
3. Social life. What impact does the illness have on the relationship with others? 
4. Illness-specific fears, the psychological affect of the illness. 
5. Psychological wellbeing, referring to mood.  
CLAU-S was translated into Swedish following the guidelines for forward-backward 
translation 92 prior to being used in this study. The translated version was then 
translated back into the source language in order to verify the translation 93. Twenty 
persons suffering from peripheral arterial disease tested the questionnaire in order to 
obtain the linguistic validation. Cronbach’s alpha coefficient was calculated for the five 
dimensions (Table 3). 
 
Table 3. Cronbach’s alpha coefficient calculated for the five CLAU-s dimensions 
Dimension Items Cronbach’s alpha Cronbach’s alpha
 Swedish version English version
Daily life 9 0.90 0.90
Pain 10 0.74 0.74
Social life 4 0.80 0.73
Illness-specific fears 13 0.67 0.91
Psychological well 
being 11 0.90 0.89
 
 
EuroQol 5D (EQ5D) 
EQ5D, a generic instrument, was used to assess the seriousness of conditions at 
different times (baseline, one-month follow-up and one-year follow-up). EQ5D defines 
health in five dimensions: mobility, self-care, pain/discomfort, usual activities and 
anxiety/depression. Each of the five dimensions has three response categories 
corresponding to ‘no problem’, ‘some problem’ and ‘extreme problem’. EQ5D also 
includes a self-rating of health status on a visual analog scale (VAS), called EQ VAS.  
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It is a quantitative measure, illustrated as a 20-centimeter vertical VAS, where the 
endpoints are 0 for ‘worst imaginable health state’ and 100 for ‘best imaginable health 
state’ 94-96. 
 
Sense of Coherence scale (SOC) 
The SOC short version (13 items), developed from the original 29-item scale, was used 
to estimate the patients’ sense of coherence 80. The scale consists of three dimensions: 
Perceived comprehensibility (five items), Manageability (four items) and Meaningfulness 
(four items) and has a 7-point Likert-scale format, ranging from ‘never’ to ‘very often’. 
The total range of the scale is 13-91 points. The scale is regarded as valid and reliable 97 
and can be separated into three groups: low (30-60 points), moderate (61-75 points) and 
high (76-91 points) sense of coherence 98. 
 
 
Qualitative interviews 
The purpose of the qualitative interviews conducted in Paper III and IV was to gain rich 
and deep data about the experiences of living with intermittent claudication (cf Patton, 
2002) and to focus on the insider’s perspective as described by both the ill person and 
the spouse 11, 17. The core of qualitative inquiry is the understanding of phenomena 
from different perspectives, inside or outside, and interviewing is one of the most 
common methods of data collection within qualitative studies. To understand the 
insider’s perspective, the interview provides opportunities to find out what other people 
have in and on their minds, like feelings or thoughts, that can not be observed from the 
outside or captured through questionnaires 90.  
 
The interview method used in Paper III and IV was what Patton 90 calls the general 
interview guide approach, or what Kvale and Brinkmann 91 calls the semi-structured 
interview. An interview guide is then used to assure certain topics are covered in the 
interviews, in this case pain, mobility, daily life and social life (friends, family etc.). 
The interviewer is however free to shape the phrasing or order of the questions 90-91. 
Before the interview started, the aim of the study was again stated and the audio 
recording system was tested with a question about today’s date. The interviews then 
started with the question: “Please, tell me about your experiences of living with reduced 
circulation in the legs” (Paper III) or “Please, tell me about your experiences of living 
with someone with reduced circulation in the legs” (Paper IV). Participants were 
invited to talk openly about their experiences of living with intermittent claudication 
(Paper III) or about their experiences of living with a person suffering from intermittent 
claudication (Paper IV). Follow-up questions were asked to clarify or deepen the 
answers 91. We strove to ask the questions in a clear, neutral and singular way since the 
participant’s responses are affected by how the question is worded 90. Open-ended 
questions were used in the interviews. According to Patton 90 the interviewees were 
then able to respond in their own words and predetermined answers were avoided. 
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DATA ANALYSIS 
 
STATISTICAL ANALYSIS 
 
Table 4. Overview of statistical methods 
 
 Paper I Paper II 
Chi-square X  
T-test X X 
Mann-Whitney  X 
Kruskal-Wallis  X 
 
 
In Paper I the variables were converted into numerical data. As none of the variables, 
with the exception of age, fulfilled the assumption of normal distribution, non-
parametric methods were used. The Pearson Chi-square test was used to test the 
differences between two independent groups of nominal-level data. For age, the 
Student’s t-test was used.  
 
Repeated measurements analysis was used in Paper II to analyze time dependent data 
and statistical comparisons to test differences between two groups were made by use of 
the Mann-Whitney test. The global score and dimension scores of CLAU-S were 
adjusted to range from 0 (bad) to100 (good health related quality of life). The Mann-
Whitney test was then used to test the ordinal data from CLAU-S and the EQVAS. The 
EQ5D scores were computed by index 99 and pair-wise t-tests were used to analyze the 
differences in health related quality of life over time. The Kruskal-Wallis test 100-101 was 
used to test the differences between the groups of SOC scores regarding the CLAU-S 
scores over time.  
 
All analyses were carried out by use of the Statistical Package for the Social Sciences, 
version 14.0 in Paper I and version 16.0 in Paper II (SPSS Inc., Chicago, IL, USA). The 
5% level of significance was considered as statistically significant in Paper II and P-
values ≤0.01 were considered as statistically significant in Paper I regarding mass 
significance. 
 
 
QUALITATIVE CONTENT ANALYSIS 
The aim of qualitative content analysis is to focus on the individuals’ experiences. The 
method can be described as a process of detailed and systematic identifying, coding and 
categorization of patterns in data and in some cases interpreting them into themes 90. 
Published scientific papers using qualitative content analysis as a keyword have greatly 
increased during the 21st century 102. In analyzing interview transcripts it is essential to 
be systematic 90-91, 103 and since guidelines on qualitative content analysis require 
judgment and creativity the analyses are dependent on the skills of the inquirer 90.  
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In Paper III and IV qualitative thematic analysis was used as described by Patton 90. 
The analysis was carried out in two steps: first in a more descriptive phase where the 
experiences of living with intermittent claudication (Paper III) and the experiences of 
living with a person suffering from intermittent claudication were made (Paper IV) and 
then a second conclusive interpretive phase. The findings are presented in a different 
order in the manuscripts, where the interpretations come first followed by the 
descriptive part, which is close to the original text.  
 
Directly after each interview spontaneous first reflections were noted and proper 
functioning of the audio recording was checked. This is where analysis and 
interpretation starts according to Patton 90 and insights of the data can emerge that 
otherwise can be lost. This phase is important to promote rigor of qualitative inquiry. 
The interviews were transcribed verbatim and the transcriptions were then carefully 
compared to the original recordings. All interviews were first read to understand the 
overall meaning and thereafter read several times while the data was analyzed 
searching for patterns. With the aim of the study in mind, notes regarding the content 
were made in the margins.  
 
During the first phase of analysis, key phrases that are collections of words, sentences 
or paragraphs carrying a meaning of importance for the study, were identified and 
coded in a systematic way. Two interviews in Paper III and three interviews in Paper 
IV were first read and coded independently by all three authors. Thereafter coding was 
discussed leading to consensus, before the remaining interviews were coded. The data 
was structured in the OpenCode software 104 during the analysis process. New codes 
were constructed, others changed, renamed or merged together before the coding was 
completed and categories could be structured by grouping codes dealing with the same 
content together.  
 
These descriptive findings were then the foundation for the second interpretive phase of 
the analysis. This is when data was compared forward and backward between the 
whole and parts of the transcriptions, back and forth between data and the inquirers’ 
own perspective; categories to codes and back to categories again, while interpreting to 
themes. Conclusions were drawn and six different themes in Paper III together founded 
one main theme. In Paper IV thirteen subthemes were grouped into four different 
themes and one over-all theme emerged from the over-all findings. 
 
Representative quotations were selected to illustrate the findings in Paper III-IV and 
according to Sandelowski 105 the selection of quotations should be faithful to what the 
participant wanted to say and to the researcher’s idea of the meaning of the quote. We 
made some minor linguistic and grammatical changes, since spoken language in 
writing can be difficult to read and understand 91, 105 and sometimes even make the 
interviewees sound foolish. 
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METHODOLOGICAL CONSIDERATIONS 
One important aspect of research is the ability to judge the accuracy of research 
findings. For this reason we strove to carefully describe the research process, including 
all the different steps, as detailed as possible in Paper I-IV. Strengths as well as 
limitations of the four papers included in this thesis are reflected upon in the text below.  
 
Design 
Different methods are needed to research different aspects of a phenomenon 106. One of 
the strengths of this thesis is the use of different designs. We measure the different 
outcomes and health related quality of life among people going through PTA-
interventions by chart review and questionnaires (Paper I-II) and by interviewing 
people about their experiences we deepen the understanding of living with intermittent 
claudication as well as the spouses’ experiences of living with someone suffering from 
intermittent claudication (Paper III-IV).  
 
Inclusion 
The limitation of a sample through inclusion and exclusion criteria might lead to a 
different understanding and description of the quality of life or the experience of living 
with illness and of going through certain interventions. Ideally everybody should be 
included and no one should be excluded if one really wants to find out how quality of 
life is influenced or how living with chronic illness is experienced. Even those living 
with the illness but not yet diagnosed should be included 29. The inclusion criterion in 
Paper II was people diagnosed with peripheral arterial disease and in Paper III-IV 
people suffering from intermittent claudication. People who did not speak or 
understand the Swedish language were excluded in Paper II-IV. The implications of 
this can be discussed. However, it can be difficult in practice to conduct interviews 
without a mutual language or to locate people, not yet diagnosed, living with the 
illness29. 
 
At the planning stage the sample in Paper II was designed to be consecutively included. 
According to logistic problems due to reorganization and centralization of the vascular 
surgery unit we had to include participants when given opportunity. The inclusion of 
participants came to an end one and a half year later. The fact that the inclusions were 
not controlled might affect the external validity. In the sample the range of age was 47-
87 years and sex was equally divided (21 men, 20 women). The majority had 
symptoms classified as intermittent claudication (85%). Only 15% had symptoms 
classified as critical limb ischemia. Whether this was the normal distribution of these 
two groups in PTA-interventions overall at the hospital was not inquired in this paper 
and should be taken into account.  
 
The participants in Paper III were chosen to include various ages and both sexes as well 
as various lengths of the experience of living with intermittent claudication. Thus 
broadening the descriptions of the phenomenon and thereby giving credibility to the 
study 90. The age of the participants varied between 64 and 81 years, all but one of them 
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were retired. This should be taken into account concerning the transferability of the 
results 90. 
 
Asking participants from one study (Paper III) for permission to include their family 
members in another study (the sample of Paper IV) might be seen as a way of 
convenience sampling 90. There was however a broad range in age and both women and 
men were included and all in all they gave a rich description of the experiences of 
living with someone suffering from intermittent claudication. The result is an 
opportunity to view two different sides of a joint life with intermittent claudication. 
 
Data collection 
One strength when developing the protocol of Paper I was the clinical experience of 
taking care of patients going through PTA-interventions. This experience together with 
issues based on scientific literature were included in effort to strive to avoid 
overlooking any variable. One ambition of Paper I was to describe the nursing care of 
patients going through PTA-interventions. Nursing variables such as pain, ulcers and 
home help service included in the protocol were not included in the results because 
documentation concerning these variables was rarely present in the patient records. 
Although these variables were checked for availability in random patient records during 
the protocol development, it may be that the assessed records were not representative as 
the variables were rarely found in the study sample records. 
 
Questionnaires 
When testing the questionnaire in Paper II the response rate of one question under the 
dimension “illness specific fears” were low because people who did not have a partner 
found it hard to answer the questions with the alternatives given. The question was 
“How worried or afraid were you in the past week about your partner turning away 
from you?” One new alternative answer to this question was added (“not relevant”) to 
prevent having questions unanswered. Original response alternatives were: not at all, 
somewhat, moderately, quite a bit, very much. In the analysis the answer “Not 
relevant” was converted to “Not at all” since in this case there was no worry that the 
partner would turn away. 
 
Interviews  
The participants chose the place and time for the interviews in Paper III-IV and most of 
the interviews were carried out in the participants’ homes in familiar and relaxed 
surroundings. To ensure that stress was not an issue that could have affected the 
interview, there was no time limit. Whether the interviews were carried out in the 
participants home or in a room at the author’s working place or at the hospital it was 
carried out in a quiet, undisturbed setting as Kvale and Brinkmann 91 recommends. 
During two of the interviews in the participants’ homes a family member entered the 
room interrupting the interview. This could have influenced the findings since it took a 
while to come back to the interview and follow-up questions were missed in one of 
these interviews.  
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The interviews differed from each other both regarding the way the interviewees 
expressed themselves and how long the different interviews lasted. Regardless of these 
variations the interviews all together gave a rich description of the experiences of living 
with intermittent claudication.  
 
Analysis 
Regarding the accuracy of data in Paper I, errors may have occurred at three different 
stages. First during examinations of the patients and second during documentation in 
the patient records made by the nurses/surgeons. Thirdly this could also have happened 
later, during the collection and interpretation of data 107. Since the same person took 
part in the development of the protocol as well as carried out the data collection there 
was a risk of the pre-understanding affecting what data would be found. In an attempt 
to avoid this, the records were thoroughly examined. The fact that only one person 
carried out all the data collection can also be seen as strength since data were not 
interpreted differently and handled equally.   
 
In Paper III-IV, all authors first read and coded some of the interviews independently; a 
form of analytical triangulation, various ways of scrutinizing the data can provide 
important understandings 90. This was followed by a discussion leading to common 
understanding and agreement of the coding. This contributed to increase 
trustworthiness. The categories were judged both by internal homogeneity and external 
heterogeneity to strive for their independence 90.  
 
The experiences of living with intermittent claudication and living together with 
someone suffering from intermittent claudication are described close to the original 
wording of the interviews in the descriptive part of Paper III-IV. This gives the readers 
a chance to make their own interpretation even though we strove to present the most 
probable interpretation 108. Representative quotations were selected to illustrate the 
findings in Paper III-IV and to gain credibility 108. 
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ETHICAL CONSIDERATIONS 
The foundation of research ethics is based on the reseacher’s own ethical responsibility 
to make sure the reseach is morally acceptable and of good quality. The reseacher’s 
professional work ethics must also be respected (CODEX the Swedish Research 
Council website)109. The studies included in this thesis are approved by The Karolinska 
Institutet Ethics Committee North (Dnr 03-012, 03-803) and The Regional Ethical 
Review Boards (2008/1510-31, 2005/52-31).  
 
Ethical consideration concerning the participants in the studies follow the International 
Counsil of Nurses Codes of Ethics for Nurses (ICN, 2005) 110 and the principles of the 
World Medical Association Declaration of Helsinki (Oct 2008)111. These ethical 
principles include paying attention to the potetial risk of violating human dignity, 
integrity, the right to self-determination, privacy, confidentiality and also the 
researcher’s responsibility towards employers and sponsors and are discussed in the 
text below. 
 
The participants in Paper II-IV were guaranteed confidentiality and informed that their 
participation was voluntary and that they had the option to withdraw at any time 
without giving a reason. They all gave their informed consent to participate in the 
study. The participants were free to decide where the interviews took place. With 
permission from the participants the interviews in Paper III-IV were audio recorded. 
The participants approved the use of quotations from the interviews to illustrate the 
findings and they were also informed that data would only be published on a group 
level. In Paper I the scope of the approval by the Ethics Committee permitted data 
collection from patient records.  
 
The issue regarding dependency relationship always has to be considered when asking 
for participation in a study. This issue could have been raised in Paper II since a nurse 
working on the vascular surgery ward assisted in the inclusion of the participants. The 
nurse was however not involved in the study in any other way. In Paper III-IV the 
participants were asked for participation by the interviewer (L.E.), not involved in their 
care or treatment. 
 
The study specific protocols (Paper I), the questionnaires (Paper II) and the interview 
transcriptions (Paper III-IV) were coded and the codelists were kept safe as well as the 
data-storage containing all interviews. All personal matters were treated confidentially. 
No names or other conceivable personal data that could expose the participants’ 
identities were used in the transcriptions or during the analysis. In order to keep track of 
the recordings the interviews were named by the date of the recording (expressed when 
testing the audio recording equipment).  
 
When interviewing people about their experiences, ethical dilemmas may sometimes 
arise if the questions are seen as intrusive. The interview could bring forth painful 
memories, open old wounds or remind the interviewee of dreams never fulfilled. The 
interviewee can become aware of things they have not reflected upon before the 
interview and this new knowledge about themselves may affect them. On the other 
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hand the interviews can also be seen as relieving or healing. How the interview will 
affect the interviewee cannot be foreseen but it is important to keep this in mind during 
the interview process 90. The participants in Paper III-IV received the telephone number 
of the interviewer in case any matters arose after the interview. A surgeon or a 
counselor could then be contacted if needed.  
 
Funding of this thesis primarily came from the author’s (L.E.) employers and to some 
extent grants from foundations that did not lay any claims to, or opinions about, the 
contents of the studies. 
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MAIN FINDINGS 
The papers in this thesis are numbered in the order in which they were carried out. Here 
they are presented in another, perhaps more logical order beginning with the 
experiences of living with intermittent claudication followed by the experiences of the 
spouses. Thereafter, the outcomes of PTA-intervention and finally the health related 
quality of life after PTA are presented.  
 
 
EXPERIENCES OF LIVING WITH INTERMITTENT CLAUDICATION 
Paper III addressed the experience of living with intermittent claudication. The findings 
are described in six themes: Experiencing discomfort in the leg; Moving around in a 
new way; Feeling inconvenient when forced to stop; Missing previous life; 
Incorporating intermittent claudication in life and To lead a strenuous life. Those 
themes together founded the main-theme: Adjusting to a restricted life. 
 
Living with intermittent claudication means adjusting to a restricted life. 
 
Intermittent claudication greatly influenced daily living. Suffering from intermittent 
claudication was hovering between wellness and illness. Feeling well when being 
indoors or sitting still and feeling ill when walking or not being able to do what they 
wanted. The mere thought of walking could be stressful and made them avoid going out 
at all. Spontaneous actions were not possible to the same extent anymore and they tried 
to maintain life through careful planning and constant adjusting.  
 
Changes in the way of moving around were required and alternative transportation 
always had to be considered. When out walking and pain became overwhelming they 
had to find a suitable place to stop for a rest. Otherwise they expressed a sense of 
inconvenience, a feeling of awkwardness or even emotional vulnerability due to the 
fact that the symptoms were not visible. If no such place was found they could pretend 
to be waiting for someone, consulting their watch or being interested in something 
beside the road to justify the place where they stopped. 
 
The illness gave a feeling of being left out of different situations and contexts, being 
forced to restrictions. The participants expressed that they had to avoid certain activities 
like travelling with their families or taking part in joint walks and had become 
dependent on others. Facing the fact that intermittent claudication means a limitation in 
daily life and learning to live with that was laborious on top of the overall burden of 
illness.  Living with intermittent claudication is living with an invisible illness filled 
with worries for the future.  
 
 
SPOUSES’ EXPERIENCES OF LIVING TOGETHER WITH A PERSON 
SUFFERING FROM INTERMITTENT CLAUDICATION 
Paper IV addressed the spouses’ experiences of living together with someone with 
intermittent claudication. Four themes were identified: Frustrating to not meet 
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intentions; Undergoing changes in social life; Being a person on the side of things and 
Intertwining of circumstances. Those themes together founded the overall theme: 
Living a demanding life.  
 
In this study we found that living together with a person suffering from IC was living a 
demanding life. 
 
It was difficult for the spouses to always be concerned for someone else’s wellbeing 
and not having full freedom. It was also trying to always show consideration and 
sometimes hard to understand the ill person’s situation. The ill person often let their 
irritation or the bad mood out on the people closest to them, which the spouses saw as 
unfair. On the whole the spouses had to lower their level of intentions and expectations 
both at home and in life in general.  
 
The spouses’ lives had become restricted, sometimes even confined to the house 
because of the ill persons’ symptoms. It could be trying not being able to make plans 
and be forced to take each day as it comes, not being able to move about freely and 
they often felt they had to sacrifice a lot. If they were the kind of couple who used to do 
everything together there was a big change. The walks they used to take together, this 
very special way of being together was something they really missed. The spouses who 
had activities on their own did not notice the change as much. For some spouses the 
practical sides of daily life at home almost remained the same. 
 
Watching someone close to you suffer from pain, walking disability or isolation could 
be hard. A feeling of powerlessness was expressed, just being a person standing on the 
side. It was demanding and mentally straining to both emotionally and physically 
support someone who used to be the stronger one. The spouses worried about the future 
and often wondered why the ill person had not sought medical care at an earlier stage. 
 
Apart from the fact that the ill person’s symptoms of PAD could take a turn for the 
worse, there were often other infirmities, different diseases or other aspects related to 
old age affecting the experience of the situation. The spouses own diseases or 
infirmities that were concomitants of old age also had to be taken into account. 
Sometimes the social life was affected more by other disabilities than the impaired 
circulation.  
 
 
OUTCOMES AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY 
The characteristics and outcomes of PTA-interventions proximal and distal to the 
inguinal ligament were described in Paper I. The majority had had symptoms classified 
as intermittent claudication (N=105) and later amputation was more common in the 
ischemia group than in the claudication group (p<0.001). The patients were younger in 
the proximal group (p=0.002) and more frequently smokers or former smokers 
(p<0.001).  
 
Hematoma/bruise as a complication was more common among non-diabetic patients 
versus patients diagnosed with diabetes (p=0.001). Most of the patients who had 
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undergone amputation died during the observation period compared to those not 
requiring amputation (p<0.001). Twenty-six PTA-patients (14%) were amputated 
during the observation period. Eleven out of 38 patients (29%) who had undergone re-
operation were amputated compared to 15 of the 150 (10%) not re-operated (p=0.003).  
 
Forty percent died during the observation period (follow-up range was 39-95 months). 
When comparing patients’ living situation and mortality, 61% of the deceased patients 
were living alone, compared to 35% of the survivors, (p=0.001). Fifty-four percent of 
the patients diagnosed with heart disease died during the observation period compared 
to 32% of the patients without heart disease diagnosis, (p=0.002). Twenty-four of the 
76 patients who died had previously undergone vascular operations (32%) compared to 
13 out of the 112 survivors (12%), (p=0.001). 
 
 
 
HEALTH RELATED QUALITY OF LIFE AFTER PERCUTANEOUS 
TRANSLUMINAL ANGIOPLASTY 
In Paper II the HRQoL was improved both at the one-month follow-up and the one-
year follow-up compared to baseline (see Fig 1 and 2). When comparing SOC and 
CLAU-S, there was a difference between the groups with low and moderate sense of 
coherence as well as between the groups with low and high sense of coherence 
regarding HRQoL (see figure 3).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
______________________________________________________________________ 
Figure 1. Every aspect of HRQoL described in the CLAU-S questionnaire was 
affected. 
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__________________________________________________________________ 
Figure 2. EQ5D computed by index improved significantly both at the one-month 
follow-up to 0.7504 (p=0.0006) and the one-year follow-up to 0.7328 (p=0.0019) 
compared to baseline, 0.5427. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
______________________________________________________________________ 
Figure 3. Influence of Sense of Coherence (SoC) score on CLAU-S score. 
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DISCUSSION 
Intermittent claudication as a symptom of PAD has a great influence on daily life. 
Depending on the severity of the symptoms and their former lifestyle, people suffering 
from intermittent claudication describe in the interviews how this affected their daily 
life in different ways. A moderate reduction of the walking ability could be hard to 
cope with for a formerly very physically active person while it could be quite 
acceptable for a less active person. With this in mind treatment of people suffering 
from peripheral arterial disease should focus more on the patient as an individual rather 
than focusing on the disease and the walking distance. Combining the assessment of 
functional appraisal e g treadmill testing 59 and the ill person’s subjective appraisal of 
how the symptoms affect that individual is an effective way to find out how the person 
is really affected by the symptoms. Measuring only objective function will not give the 
proper picture of living with PAD because as stated by Breek 112, “Objective 
functioning and subjective appraisal are complementary and not identical”. To deepen 
knowledge and understanding of the experiences of people living with PAD and their 
family members it is important to listen to their stories.  
 
Impaired walking ability 
The symptom intermittent claudication, is cramping or aching in the leg while walking 
which is relieved by a rest 1. This means that people suffering from intermittent 
claudication are forced to stop and not always in a suitable place. The participants 
suffering from intermittent claudication described the importance of finding the right 
place to stop for a rest. They wanted the appearance of an apparent reason; otherwise 
they expressed a sense of inconvenience, partly because they felt observed. The 
participants could not really explain why they felt and behaved like this but one reason 
could be to avoid being seen as disabled. Treat-Jacobsson et al 12 and Crosby et al 54 
had similar findings, where the reduction of the walking ability lead to feeling 
abnormal, conspicuous and different when being forced to stop repeated times when 
out walking. Among the participants the uncomfortable feeling when stopping could 
also depend on the fact that the symptoms were not visible. Having a good reason to 
stop when walking alone could feel better or walking in the company of someone 
because they then could find a reason to stop while pointing at something they 
pretended to be interested in. Some did not have a partner or friend to walk with and 
others felt they did not want to be a bother to anyone else and for that reason refrained 
from walking. To avoid being out walking with all that this implies as a means of 
exercise may also have negative effect on their health situation since exercise therapy 
improves the walking ability and works as a sustainable choice of treatment in 
peripheral arterial disease 113. The participants described the value of walking together 
with others since it becomes more natural to walk at a slower pace and to stop 
somewhere for a rest. Some of the participants even expressed that they would have 
preferred organized exercise. Supervised exercise has been shown to increase walking 
ability which was associated with improvements of quality of life in all but one study in 
a review 114 of all exercise-based interventions between 1989-2008 assessing quality of 
life in people with intermittent claudication.  
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Health related quality of life and outcomes after percutaneous transluminal 
angioplasty  
The HRQoL was improved both at the one-month follow-up and at the one-year 
follow-up after PTA-intervention compared to baseline. Improved HRQoL after PTA 
has also been presented in other studies 4-9, 115. Measuring the patient’s perspective of 
medical outcomes should play a role, just as important, as established measures like 
treadmill walking distance or patency rates, to determine who should receive PTA 
treatment 10 as well as to evaluate the outcome of PTA. Patient reported outcomes are 
important to capture the full picture of the effects not only of the disease, but also of the 
treatment because clinicians tend to underestimate or overestimate HRQoL in patients 
and rely too much on the severity of the disease 116. Aquarius et al 117 studied if the 
subjective reports of impaired health status and QoL of people with intermittent 
claudication were significant determinants in physicians’ clinical decisions of invasive 
interventions. They found that poor physical functioning both reported by the patient 
and measured by treadmill walking were predictors of invasive treatment, while 
perceived experiences of poor physical functioning were not.  
 
When comparing sense of coherence with the SOC and health related quality of life 
with CLAU-S in patients with PAD undergoing PTA, there was a difference between 
the groups with low and moderate SOC, as well as between the groups with low and 
high SOC regarding HRQoL. The group with low SOC scored worse in HRQoL in 
relation to those with moderate and high SOC. Patients with high SOC scores estimated 
their quality of life higher than patients with low SOC scores had done in other  
studies 7, 80-81. Together with ankle brachial index a high sense of coherence score was 
the only independent predictor for high scores in QoL in a previous Swedish study 
regarding surgical revascularization of PAD 7.  
 
Regarding outcomes of PTA we found that a higher percentage of the patients in the 
proximal group were younger and were also smokers or former smokers. As 
Willingendael 36 recommends, we chose to put smokers and former smokers in the 
same group because the prevalence of PAD among former smokers is closer to that of 
current smokers than the prevalence of PAD among never-smokers. Smokers or former 
smokers have more proximal problems 118 and it is well known that smokers are 
diagnosed with PAD approximately ten years earlier than non-smokers 32. Amputation 
was a strong predictor of death during follow-up since most of the patients who had 
undergone amputation died during the observation period compared to those not 
requiring amputation. A possible explanation for this could be that people requiring 
amputation had more severe underlying arteriosclerosis, which is a strong predictor of 
death 32, whereas amputation as an intervention is not. Concerning complications after 
PTA we found 52 patients (28%) with hematoma/bruise recorded as a complication. 
This is a high rate compared to previous studies 86-87, 119 and this discrepancy may be 
the result of the fact that all hematomas/bruises documented in the patient records were 
included in this study, no matter their size. In earlier studies the criteria for defining a 
hematoma were not provided, which might mean that smaller bruises were excluded. 
Another finding regarding complications after PTA was that hematoma/bruise as an 
access site complication was three times more common among non-diabetic patients 
than those with diabetes. A possible explanation for this could be that people diagnosed 
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with diabetes have less severe proximal arteriosclerosis of the lower limb compared to 
people with PAD not diagnosed with diabetes 118, 120.  
 
Missing previous life 
People living with PAD describe how the disease changes and effects the body and its’ 
functions, i.e. the walking ability, and how they are not able to control these changes. 
When pain became overwhelming it was not possible to continue and they expressed 
how they just had to stop for a rest. Even if it is never possible to totally control even a 
healthy body, there is a significant change when a person is stricken by illness 26. Those 
suffering from PAD also describe how the pain affects them differently, different days. 
Furthermore they missed their previous life when they were healthy and not as 
restricted as is also described in previous studies 13, 52-54. To perform certain activities 
and belonging to certain social networks is a part of the self-image. A feeling of no 
longer belonging or contributing challenges peoples’ self-image and personal 
identity121.  
 
The participants with intermittent claudication expressed that the situation was hard to 
accept because at rest they felt much healthier than they actually were and they did not 
want to be seen as invalids. At the same time they expressed that they felt worse than 
what was visible from the outside. They stated that people around them could think of 
them as more unwell than they felt or vice verse and the fact that they did not have the 
same idea about their illness as those around them and the fact that those around them 
did not understand what it was like having these symptoms was seen as a problem. 
They wanted to take care of themselves and not be pointed out as someone miserable or 
someone to feel sorry for. This could mean refraining from doing things they wanted to 
do rather than accepting help from others and being a burden to others. The feeling of 
being a burden to others has been seen in previous studies of living with PAD 12-13 but 
also in other studies concerning chronic illnesses such as chronic heart failure as 
presented in a review by Jeon et al 122. To be clear with how you want to be treated can 
be very important for the person living with illness since people around have a 
tendency to not ask or simply take for granted that the ill person always needs help with 
everything which is something that can lead to both conflict and grief 22. Being 
restrained from handling everyday tasks or walking certain distances could be 
exasperating for the ill person and the whole situation could make them furious. All this 
affected their mood negatively and in the end affected the people around them leading 
to quarrels between spouses, for example. This issue was also brought up in the 
interviews with the spouses. The ill person often took their frustration out on the people 
closest to them. This was something the spouses saw as unfair but had to cope with. 
Some of the spouses thought that they ought to be more understanding than they 
actually were but it was hard to understand the pain or the reduced walking ability 
when they did not feel it themselves.  
 
The participants living together with someone suffering from intermittent claudication 
missed their earlier life together and the relationship could be negatively affected, at 
least temporarily. Out of consideration for the ill person they did not do any of their 
former activities. They could end up sitting together on the sofa at home without 
anything to do which could be very frustrating. The personal relationship could be 
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affected by the bad moods or irritation for both spouses just as Brubaker 123 has 
reported for other couples with diminishing health. The spouses of people with chronic 
illness could develop a feeling of being trapped and often have to make difficult 
choices between themselves and the ill person 31, 77. Engström et al 30 describe that for 
spouses it could mean putting themselves in second place to be able to support the ill 
person. Previous studies have found that when spouses prioritize themselves they can 
develop feelings of guilt 31, 77 and when they prioritize their ill partner they develop 
feelings of isolation and reduction of freedom 55. The spouses in our study found it hard 
to give up their common life and missed the togetherness during joint walks and their 
ill partner's walking impairment also resulted in less social activities as also seen in 
previous studies 55, 77, 124. The participants living with someone suffering from 
intermittent claudication worried about the future and expressed that it was mentally 
straining to both emotionally and physically have to support someone who used to be 
the stronger one. This has been seen in earlier studies 31, 77 where spouses of people 
living with illness do not only worry about their partners but also about the 
consequences of the illness for their own situation.  
 
Incorporating intermittent claudication in daily life 
The interviews with people suffering from intermittent claudication reveal that the 
participants to some extent have learned how to manage every day life with the 
symptoms. A woman expressed that she now knows that there are certain things she 
can do and other things she cannot do and that is just the way things are. One has to 
concentrate on the important things in life instead. Wann-Hansson et al 125 interviewed 
people with peripheral arterial disease about their long-term experiences and the 
recovery following revascularizations. They found that when people learned how to 
handle restrictions in life they were able to move forward and to handle their life 
situation in a better way. This can be related to the women with multiple sclerosis in the 
study of Olsson et al 126 who did not take things in life for granted and with a different 
perspective on life, could focus on the important things in life. 
 
To maintain every day life as normal as possible is important to handle life with  
illness 24. To struggle for normality is linked to understanding why one has become ill 
and also understanding the changes in ones life situation and finding new ways to 
integrate these changes in life 15. Things taken for granted earlier in life are not working 
anymore 19 but it is possible to adapt to the new life situation that includes the illness by 
finding strength in the will to feel better and to regain control of daily life 27 or by 
becoming aware of the things that are good and healthful in life. Some of the 
participants suffering from intermittent claudication stated that nothing they wanted to 
do was unsolvable. They just had to do it in another way, like taking the car or asking 
people to visit them instead of the opposite. What living a normal life means has to be 
considered from their own perspective, a perspective that now includes the illness and 
its’ symptoms as well as how these symptoms are handled. To find balance in life the 
ill persons can develop different strategies where they try to keep their positive attitude 
and to accept the situation (living with chronic illness) 24. The participants stated that 
feeling bitter or complaining about the situation would do no good and was definitely 
not the solution. One way to handle such feelings was to imagine things could always 
be worse. By making changes in life style and by accepting certain limitations in life 
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they can continue to lead a normal life 24. Incorporating intermittent claudication in life 
could be facing the fact that the symptoms mean a limitation in daily life. The 
participants now had to conform their daily life into a life with a walking disability. 
Living with chronic illness radically changes life. Seeking normality is a part of living 
with the illness and the ill persons themselves become experts on how to live with the 
illness, sometimes with the illness only in the background and sometimes it dominates 
life 29. This corresponds to what Öhman et al 15 showed, those living with chronic 
illness fought to live their life as normal as possible and learned to live with their illness 
by for instance avoiding certain situations that could make the illness worse.  
 
Peripheral arterial disease and other infirmities   
In the interviews with the spouses we found that apart from the fact that the ill person’s 
symptoms of PAD could take a turn for the worse, there were often other infirmities, 
different diseases or other aspects related to old age affecting the experience of the 
situation. Sometimes the social life was affected more by other disabilities than the 
impaired circulation. This could be related to that symptoms of intermittent 
claudication often come gradually and could be mistaken as being a consequence of the 
ageing process 54. The coexistence of natural ageing and illness makes it hard to 
distinguish the effects of one specific diagnosis and the symptoms thereof on daily life, 
since reduced mobility according to Person et al 127, is also a part of natural ageing.  
Sometimes other infirmities can be hidden behind the symptoms of PAD. Wann-
Hansson et al. 125 found that the revascularization also revealed other ailments when 
people suffering from PAD were relieved of the PAD symptoms. These “new” 
symptoms could derive from other diseases or from the underlying arterial disease, for 
example cardiac symptoms 125. The spouses of people suffering from intermittent 
claudication expressed that they also had infirmities of their own and this could be 
straining for both themselves and the ill person. In the interviews with people suffering 
from intermittent claudication, the other infirmities, diseases or other aspects related to 
old age did not surface as clearly. A possible explanation for this is that it is easier for 
them to define and separate one infirmity/symptom from another while the spouses, 
who see the ill person and his/her situation as a whole, might have difficulties to tell the 
different infirmities or symptoms apart. It is important to be able to see the whole 
picture of the ill person and the ill person’s life and for this reason it is essential to gain 
knowledge from the spouse’s perspective. Jeon 24 describes how medical expertise, 
often focusing on their own field, rarely is able to see the whole picture. The spouses 
own diseases or infirmities that are concomitants of old age also have to be taken into 
account since today they are important as informal caregivers. Apart from the 
importance of having the spouse’s perspective to deepen the understanding of the ill 
person’s experiences and daily life, it is also important to have the spouse’s perspective 
for their own sake, to be able to treat and support them. 
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CONCLUSIONS AND CLINICAL IMPLICATIONS 
 
• Living with intermittent claudication has a major impact on daily life and 
demands adjustment to a restricted life. Apart from the severity of symptoms, 
experiences of living with the illness are different depending on how active the 
ill person is or wants to be.  
 
• Ageing and living together with someone suffering from intermittent 
claudication, a symptom that has great impact on both the spouse’s and the ill 
person’s life, is demanding and complex. 
 
• Percutaneous transluminal angioplasty improves health related quality of life 
among individuals suffering from peripheral arterial disease and the effect is 
also sustainable over time up to one year after the intervention. 
 
• No differences in outcome were found between patients who had undergone 
percutaneous transluminal angioplasty whether proximal or distal to the 
inguinal ligament; however the patients were younger in the proximal group. 
Hematomas/bruises as a complication after percutaneous transluminal 
angioplasty were more common among non-diabetic patients. 
 
This thesis contributes to the knowledge and understanding of the life situation of 
people living with peripheral arterial disease and their family members and emphasize 
the importance of having both the ill person’s and their family members’ experiences of 
the situation when supporting them or making decisions regarding treatment. It seems 
to be important to ask family members about their health status and life situation in 
order to properly support them. With the shorter hospital stays of today, people with 
illness are discharged from the hospitals with extensive needs of help and care. It is 
often taken for granted that spouses or other family members can give this help and 
support. The symptoms of peripheral arterial disease have a great influence on daily life 
but affect daily living in different ways depending on the severity of the symptoms and 
the ill person’s former lifestyle. 
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FUTURE RESEARCH 
As shown in this thesis peripheral arterial disease has great impact on the daily life for 
both individuals suffering from intermittent claudication and their spouses and that 
health related quality of life increased for those undergoing percutaneous transluminal 
angioplasty. Regarding experiences, two sides of the same coin, emerge in the 
interviews with individuals suffering from intermittent claudication and their spouses 
respectively. Future studies could deepen the understanding of the ill person’s and the 
family member’s different perspectives and could be the foundation for better treatment 
and support for both. In future studies it would be of interest to find out: 
 
• the strategies people living with peripheral arterial disease and their family 
members have for handling daily life.  
 
• the different experience from the perspective of the men and women who live 
together with someone suffering from peripheral arterial disease. 
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POPULÄRVETENSKAPLIG SAMMANFATTNING 
Livssituationen hos personer med benartärsjukdom och deras närstående 
 
Att leva med långvarig sjukdom kan ofta leda till att livet blir inskränkt, att man tappar 
kontrollen över livet och social isolering. Både fysiska och sociala funktioner påverkas 
ofta negativt och att leva med sjukdom kan också ge en känsla av att bli en börda för 
andra. 
 
Livssituationen hos dem som drabbas av benartärsjukdom och den nedsättning av 
gångförmågan som det innebär leder till stora inskränkningar i det dagliga livet och 
bidrar till en försämrad livskvalitet. Den vanligaste orsaken till benartärsjukdom är 
arterioskleros som leder till förträngningar i blodkärlen som i sin tur leder till ischemi 
(syrebrist) i benmusklerna. Detta kan visa sig på olika sätt. Mindre grav ischemi kanske 
inte märks alls eller visar sig som claudicatio intermittens (fönstertittarsjuka). Den 
drabbade får då ont i benen efter att ha gått en viss sträcka och måste sedan vila, för att 
bli av med smärtan. Värre symtom som vilosmärtor eller sår och gangrän benämns som 
kritisk ischemi. Riskfaktorerna bakom arterioskleros är rökning, högt blodtryck, 
diabetes och höga halter av blodfetter. Risken att drabbas ökar också med åldern. 
 
Det övergripande syftet med avhandlingen var att öka förståelsen för livssituationen 
hos personer som lider av benartärsjukdom och deras närstående. 
 
De personer som ingår i två av de fyra delstudierna har genomgått perkutan 
transluminal angioplastik (PTA), d.v.s. ballongvidgning av förträngningar i kärlen som 
är en behandlingsmetod vid benartärsjukdom. Ingreppet innebär att med hjälp av en 
tunn kanyl föra in en specialkonstruerad kateter i kärl med stenoser eller ocklusioner. 
Katetern är utrustad med en ballong i ena änden och denna ballong placeras i höjd med 
förträngningen och blåses upp varpå kärllumen dilateras och blodgenomflödet 
förbättras. 
 
Syftet med Delarbete I var att beskriva medicinska effekter och påverkan på det 
dagliga livet hos personer som genomgått PTA över och under ljumskligamentet 
mellan åren 1998 och 2002 på ett sjukhus. Det var en journalgranskningsstudie där ett 
undersökningsprotokoll utarbetades och användes vid insamling av samtliga data. 
Resultaten visade att det fanns ett samband mellan ingrepp ovanför ljumsken och ålder 
liksom mellan ingrepp ovanför ljumsken och rökning. De som genomgått 
ballongvidgning över ljumsken var yngre och oftare rökare än de som genomgick 
ballongvidgning under ljumsken. Blödning eller blåmärke som komplikation efter 
ingreppet var vanligare hos de som inte hade diabetes. 
 
Syftet med Delarbete II var att undersöka hälsorelaterad livskvalitet hos personer med 
benartärsjukdom som genomgått PTA upp till ett år efter ingreppet. Data samlades in 
med hjälp av två olika hälsorelaterade livskvalitetsformulär, ett generellt (EQ5D) och 
ett sjukdomsspecifikt (CLAU-S), som inför den här studien översattes till svenska. 
Resultatet visade att ingreppet förbättrade den hälsorelaterade livskvaliteten hos 
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personer med benartärsjukdom i jämförelse med hur livskvaliteten skattades före 
ingreppet och höll sig stabil fortfarande ett år efter ingreppet.  
 
Syftet med Delarbete III var att beskriva upplevelsen av att leva med claudicatio ur ett 
inifrånperspektiv. Kvalitativa intervjuer genomfördes med 15 personer som har 
benartärsjukdom med claudicatio som symtom. Intervjuerna analyserades med 
kvalitativ innehållsanalys och sex teman bildade tillsammans huvudtemat som handlade 
om att anpassa sig till ett begränsat liv. Upplevelsen att leva med claudicatio beskrevs 
som besvärlig eftersom de drabbade fick anpassa sig till ett begränsat liv, där noggrann 
planering krävdes och spontana handlingar nästan var omöjliga. Att behöva stanna på 
”onaturliga” ställen när smärtan blev för svår kunde upplevas som besvärande och 
pinsamt. 
 
Syftet med Delarbete IV var att beskriva upplevelsen av att leva tillsammans med 
någon som lider av claudicatio. Tio makar och sammanboende till de som lever med 
benartärsjukdom och har claudicatio som symtom intervjuades. Intervjuerna 
analyserades med kvalitativ innehållsanalys och det övergripande temat handlade om 
att leva ett påfrestande liv. De närstående oroade sig för den drabbade och det var svårt 
att se någon som inte längre kunde gå på samma sätt och kanske därigenom också 
isolerade sig. Förutom att de saknade sitt tidigare gemensamma liv, så kunde de själva 
inte längre göra saker som de tidigare gjort och det sociala livet förändrades. Resultaten 
av den här studien visar också på komplexiteten och svårigheterna av att åldras och leva 
tillsammans med någon som lider av claudicatio, då både de egna och den sjukes andra 
krämpor, sjukdomssymtom och åldrandet i sig påverkar livssituationen.  
 
För att förstå hur det är att leva med en långvarig sjukdom som till exempel perifer 
benartärsjukdom är det av stor vikt att få den drabbades perspektiv på att leva med 
sjukdom i det dagliga livet. Genom att lyssna på berättelser av personer med olika 
sjukdomar, så kallade sjukdomsberättelser, kan vi lära oss mer om hur det är att leva 
med olika sjukdomar.  
 
Denna avhandling ger fördjupad kunskap om och förståelse för livssituation hos dem 
som lever med benartärsjukdom och understryker vikten av att få med både patientens 
och den närståendes upplevelser av situationen vid möten med patienter i vården och 
vid beslut om vård och behandling. När det gäller vad benartärsjukdom ger för effekt 
mäts ofta maximal gångsträcka, vilket inte talar om hur personen upplever sin situation. 
Det är därför viktigt att ta reda på vad den gångsträckan betyder för den drabbade och 
dennes livssituation. För de som är mycket fysiskt aktiva kan också en liten 
inskränkning av gångförmågan vara mycket handikappande medan den för kanske mer 
stillasittande personer kan vara helt acceptabel.  
 
En djupare förståelse av hur det är att leva med långvarig sjukdom och hur både de 
drabbade och deras närstående påverkas av långvarig sjukdom behövs för att kunna 
utveckla vården och för att kunna bemöta de som lever med långvarig sjukdom på ett 
bättre sätt, där människors berättelser om hur det är att leva med sjukdom 
uppmärksammas. 
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Framtida studier som ger ytterligare kunskap om både den sjukes och de närståendes 
perspektiv bidrar till en rikare beskrivning av den sjukes situation. Dessa båda 
perspektiv bidrar till att se helheten av livssituationen för den sjuke och kan därmed 
ligga till grund för ett bättre bemötande och omhändertagande av dem båda. 
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